A PHASE I/II STUDY OF VORINOSTAT PLUS DAILY TEMOZOLOMIDE AND BEVACIZUMAB IN THE TREATMENT OF PATIENTS WITH RECURRENT MALIGNANT GLIOMA

被引：0
|
作者：
Reardon, David A. [1 ]
Vredenburgh, James J. [1 ]
Desjardins, Annick [1 ]
Janney, Dorothea E. [1 ]
Peters, Katherine [1 ]
Sampson, John [1 ]
Gururangan, Sri [1 ]
Friedman, Henry S. [1 ]
机构：
[1] Duke Univ, Durham, NC 27706 USA
来源：
NEURO-ONCOLOGY | 2010年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [21] BEVACIZUMAB AND NITROSOUREA IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA: A PHASE II MULTICENTER ITALIAN STUDY
    Ruda, Roberta
    Trevisan, Elisa
    Picco, Elisabetta
    Guarneri, Daniele
    Caroli, Manuela
    Fabrini, Maria G.
    Scotti, Valerio
    Soffietti, Riccardo
    NEURO-ONCOLOGY, 2009, 11 (06) : 905 - 905
  • [22] Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma
    Sathornsumetee, Sith
    Desjardins, Annick
    Vredenburgh, James J.
    McLendon, Roger E.
    Marcello, Jennifer
    Herndon, James E.
    Mathe, Alyssa
    Hamilton, Marta
    Rich, Jeremy N.
    Norfleet, Julie A.
    Gururangan, Sridharan
    Friedman, Henry S.
    Reardon, David A.
    NEURO-ONCOLOGY, 2010, 12 (12) : 1300 - 1310
  • [23] Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma
    Pan, Edward
    Supko, Jeffrey G.
    Kaley, Thomas J.
    Butowski, Nicholas A.
    Cloughesy, Timothy
    Jung, Jinkyu
    Desideri, Serena
    Grossman, Stuart
    Ye, Xiaobu
    Park, Deric M.
    JOURNAL OF NEURO-ONCOLOGY, 2016, 130 (03) : 571 - 579
  • [24] Phase II study of bevacizumab and nitrosourea in patients with recurrent malignant glioma: A multicenter Italian study
    Soffietti, R.
    Ruda, R.
    Trevisan, E.
    Picco, E.
    Guarneri, D.
    Caroli, M.
    Fabrini, M.
    Scotti, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] Phase I study of vorinostat in combination with temozolomide in patients with malignant gliomas.
    Wen, P. Y.
    Puduvalli, V. K.
    Kuhn, J. G.
    Reid, J. M.
    Lamborn, K.
    Cloughesy, T. F.
    Chang, S. M.
    Drappatz, J.
    Yung, W. K. A.
    Gilbert, M. R.
    Robins, H. I.
    Lieberman, F. S.
    Lassman, A. B.
    McGovern, R. M.
    Desideri, S.
    Ye, X.
    Ames, M. M.
    Espinoza-Delgado, I. J.
    Grossman, S. A.
    Prados, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [26] Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma
    Quinn, JA
    Desjardins, A
    Weingart, J
    Brem, H
    Dolan, ME
    Delaney, SM
    Vredenburgh, J
    Rich, J
    Friedman, AH
    Reardon, DA
    Sampson, JH
    Pegg, AE
    Moschel, RC
    Birch, R
    McLendon, RE
    Provenzale, JM
    Gururangan, S
    Dancey, JE
    Maxwell, J
    Tourt-Uhlig, S
    Herndon, JE
    Bigner, DD
    Friedman, HS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 7178 - 7187
  • [27] Phase I study of vorinostat combined with isotretinoin and temozolomide in adults with recurrent malignant gliomas.
    Penas-Prado, Marta
    Hess, Kenneth R.
    Levin, Victor A.
    De Groot, John Frederick
    Colman, Howard
    Groves, Morris D.
    Conrad, Charles A.
    Loghin, Monica Elena
    Hunter, Kathy
    Gilbert, Mark R.
    Yung, W. K. Alfred
    Puduvalli, Vinay K.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [28] Phase II study of bevacizumab plus erlotinib for recurrent malignant gliomas
    Sathornsumetee, S.
    Desjardins, A.
    Vredenburgh, J. J.
    Rich, J. N.
    Gururangan, S.
    Friedman, A. H.
    Friedman, H. S.
    Reardon, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] Phase I/II study of dianhydrogalactitol in patients with recurrent malignant glioma.
    Shih, Kent C.
    Patel, Manish R.
    Butowski, Nicholas A.
    Bacha, Jeffrey A.
    Brown, Dennis
    Steino, Anne
    Schwartz, Richard Stephen
    Kanekal, Sarath
    Lopez, Lorena
    Jones, Suzanne Fields
    Burris, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] Phase II Study of Single-agent Bevacizumab in Japanese Patients with Recurrent Malignant Glioma†
    Nagane, Motoo
    Nishikawa, Ryo
    Narita, Yoshitaka
    Kobayashi, Hiroyuki
    Takano, Shingo
    Shinoura, Nobusada
    Aoki, Tomokazu
    Sugiyama, Kazuhiko
    Kuratsu, Junichi
    Muragaki, Yoshihiro
    Sawamura, Yutaka
    Matsutani, Masao
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (10) : 887 - 895
12345